X

Course Registration


This symposium is designed to bring together basic and clinical investigators and clinicians to discuss new achievements in immune-oncology and targeted therapy in solid and hematologic malignancies. Leading researchers will present new developments in drug discovery, treatment resistance and new questions that lie ahead for fundamental understanding of new information in cancer biology to get us closer to well-tailored cancer treatment.  

This symposium is designed for clinical and academic hematologists, oncologists, oncology RNs, APRNs, basic scientists, clinical trail experts, including pharma and biostatisticians involved in clinical trial design, investigators and participants. 

This program will be held at the Sheraton Overland Park Hotel.


Upon completion of this course the participant should be able to:
  1. Discuss new frontiers of research in immunotherapy, antibodies and personalized oncology in different solid and hematologic malignancies
  2. Discuss the scientific interplay between the immune system and tumor biology and translate this from “bench-to-bedside” for the benefit of our patients with a variety of solid and hematologic malignancies
  3. Discuss mechanisms of resistance in immune-oncology and formulate new strategies in basic, translational, and clinical sciences for more rational and efficient clinical investigations in solid and hematologic malignancies
  4. Demonstrate emerging imaging technologies that allow observation of tumor biology in vivo and eventual translation into clinic
  5. Introduce ongoing clinical trials to identify new drugs, improve tolerability of existing anti-tumor therapy, and advance the science of precision medicine for the benefit of patients with different solid and hematologic malignancies

IF YOU ARE USING A MOBILE DEVICE (TABLET/CELLPHONE) YOU MUST LOGIN TO THE SYSTEM PRIOR TO REGISTERING.

This event will be held at the Sheraton Overland Park Hotel

FEES

Payment is required at the time of registration. Only registrations accompanied with payment will be accepted. Please register in advance. Fees include course materials, continental breakfast, refreshments and continuing education credit.

Physician                                                           $25

Physician Assistant                                            $25

Advance Practice Nurse                                    $25

Nurse                                                                 $25

Other Healthcare Professional                           $25

Fellow, Resident, Student or Basic Scientist      $0

Pharmaceutical Industry Representative            $400

REFUND/CANCELLATION POLICY

A full refund of registration fees, less a $15 administrative fee, will be available if requested in writing and received by October 20, 2017. No refunds will be made after that date. A $30 fee also will be charged for returned checks. (Please note that if you fail to cancel by the deadline and do not attend, you are still responsible for payment.) KU Medical Center Continuing Education reserves the right to cancel the course and return all fees in the event of insufficient registration. The liability of the University of Kansas Medical Center is limited to the registration fee. The University of Kansas Medical Center will not be responsible for any losses incurred by registrants, including but not limited to airline cancellation charges or hotel deposits.

Mark R Albertini, MD
Associate Professor of Medicine - University of Wisconsin-Madison - Madison, WI
Andrew Brenner, MD
Associate Professor - UT Health San Antonio Cancer Center - San Antonio, TX
Neil Dunavin, MD
Assistant Professor - University of Kansas Medical Center - Westwood, KS
Faculty Photos
Byron J. Gajewski, PhD
Professor, Department of Biostatistics Director, Biostatistics and Informatics Shared Resource, The University of Kansas Cancer Center Secondary Appointment in Nursing Member of Cancer Control and Population Health, The University of Kansas Cancer Center Methods Core Director, Center for American Indian Community Health - University of Kansas Medical Center - Kansas City, KS
Anup Kasi, MD
Faculty - KU Medical Center - Westwood, KS
Janice Mehnert, MD
Director of Phase I and Developmental Therapeutics Program - Rutgers Cancer Institute of New Jersey - New Brunswick, NJ
Anwaar Saeed, MD
Assistant Professor - University of Kansas Medical Center - Overland Park , KS
Priyanka Sharma, MD
Associate Professor - University of Kansas Cancer Center - Westwood, KS
Weijing Sun, MD
The Sprint Foundation Professor of Medical Oncology; Director, Division of Medical Oncology Associate Director, University of Kansas Cancer Center - University of Kansas Cancer Center - Westwood, KS
Douglas Yee, MD
Director of the Masonic Cancer Center - Masonic Cancer Center, University of Minnesota - Minneapolis, MN
Title Time Faculty Room
Registration, Exhibits, Continental Breakfast 7:00AM - 8:00AM  
Welcome 8:00AM - 8:05AM  
Neoadjuvant therapy of breast cancer as a model for drug development: The I-SPY2 experience 8:05AM - 8:25AM Douglas Yee, MD
 
CTEP Pipeline 8:25AM - 8:45AM  
Drug Development in Solid Tumors 8:45AM - 9:05AM Janice Mehnert, MD
 
Novel Therapeutic Approaches for CNS Tumors 9:05AM - 9:25AM Andrew Brenner, MD
 
Panel Discussion 9:25AM - 9:40AM  
Break - Light Snacks & Exhibits 9:40AM - 10:00AM  
The age of enlightenment in melanoma immunotherapy 10:00AM - 10:45AM Mark R Albertini, MD
 
Q&A 10:45AM - 11:00AM  
Alternate statistical Designs for Phase I and II Trials 11:00AM - 11:15AM Byron J. Gajewski, PhD
 
Break & Exhibits 11:15AM - 11:45AM  
A Biological Basis for the Immunosuppressive Effects of Umbilical Cord Derived Mesenchymal Stromal Cells 11:45AM - 12:05PM Neil Dunavin, MD
 
Investigation of novel treatment strategies for metastatic breast cancer 12:05PM - 12:25PM Priyanka Sharma, MD
 
Immunotherapy of GI malignancies 12:25PM - 12:45PM Weijing Sun, MD
 
Panel Discussion 12:45PM - 1:00PM  
Adjournment 1:00PM - 1:05PM  

All participants are required verify their attendance for the course. A certificate of completion will be provided to all activity participants based on completion of the program evaluation, documentation of actual attendance time, meeting minimum attendance requirements specific to the activity.

Physicians: University of Kansas Medical Center Office of Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The KU Medical Center Office of Continuing Medical Education designates this live activity for a maximum of TBD AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in activity.

Nurses/APRNs: The University of Kansas Medical Center Area Health Education Center West is approved as a provider of CNE by the Kansas State Board of Nursing.  This course offering is approved for 5 contact hours applicable for APRN or RN relicensure.  Kansas State Board of Nursing provider number: LT0086-1149.  Karen Aufdenmberge, BSN, RN, Coordinator. 

Continuing education credit will be issued  according to documented attendance..

Notice - Physician Information Collection:  For physician attendees, the Open Payments to Physicians (Sunshine Act) may require the company supporters(s) to report to CMS the value of some items associated with this activity.  For proper reporting, we will be asking for your NPI (National Provider Index) number and a state license number.

This organization has generously supported this symposium and we acknowledge them with sincerest appreciation: 

Partially Sponsored by the Peter T. Bohan Visiting Lecturer Fund

University of Kansas Cancer Center

PRIVACY POLICY

KU Medical Center Continuing Education does not share, sell, or rent its mailing lists. You have our assurance that any information you provide will be held in confidence by KU Medical Center Continuing Education.

We occasionally use mailing lists that we have leased. If you receive unwanted communication from KU Medical Center Continuing Education, it is because your name appears on a list we have acquired from another source. In this case, please accept our apologies.

NONDISCRIMINATION POLICY

The University of Kansas Medical Center prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University's programs and activities.  The following person has been designated to handle inquiries regarding the non-discrimination polices: Natalie Holick, Director, Equal Opportunity Office, NHolick@kumc.edu, Mail Stop 2014, 4330 Shawnee Mission Parkway, Fairway, KS 66205, 913-588-8011, 711TTY

PROGRAM ACCESSIBILITY

We accommodate persons with disabilities. Please call 913-588-4488 and a KU Medical Center Continuing Education representative will be happy to discuss your needs. To ensure accommodation, please register at least two weeks before the start of the course. See the nondiscrimination policy above. The University of Kansas Medical Center is an AA/EO Title IX institution.




© The University of Kansas Medical Center
The University of Kansas Medical Center prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University's programs and activities.  The following person has been designated to handle inquiries regarding the non-discrimination polices: Natalie Holick, Director, Equal Opportunity Office, NHolick@kumc.edu, Mail Stop 2014, 4330 Shawnee Mission Parkway, Fairway, KS 66205, 913-588-8011, 711TTY